Q2 2020 Reinsurance Group of America Inc Earnings Call
Good day, everyone welcome to the reinsurance group of America's second quarter Twentytwenty results Conference call today's call is being recorded.
This time I would like to introduce Mr., Todd Larson Senior Executive Vice President and Chief Financial Officer.
President and Chief Executive Officer. Please go ahead Mr. Miller.
Thank you.
Good morning, welcome to Archie a second quarter 2020 conference call.
This morning on the call or Aaron Marin, RG, <unk>, President and Chief Executive Officer.
Well I need.
Chief operating officer was we Barbie Chief investment Officer.
It's important global Chief risk Officer, Jeff Hopson part of our Investor Relations.
Well I'll discuss the second quarter results.
Good morning to about forward looking information and non-GAAP financial measures.
Oh, we all prepared remarks.
Happy to take your questions.
The more comments or answers to your questions may contain forward looking statements.
Actual results could differ materially from expected results.
Please refer to the earnings release, we issued yesterday.
Well, that's an important factors that could cause actual results may differ materially from expected results.
Additionally, during the course of this call information we provide.
They include non-GAAP financial measures, please see our earnings release.
This presentation.
Quarterly financial supplement and web site for discussion of these terms reconciliations to GAAP measures.
And now I'll turn the call over the air lift for her comments.
Thank you Todd good morning, and welcome to everyone on the call.
I hope you all wells and staying healthy.
You take a moment to express my heartfelt sympathies to everyone. Let's watch and then go up their family or friends.
Thank you all we're suffering from the devastating economic consequences of goods pandemic.
Health and safety of RG employees and their families continues to be a top priority.
I'd like to express my ongoing appreciation for their dedication commitment to ensuring that our global operations continue to lunch nicely and productively.
Throughout the quarter RG 18 provided.
Trusted and see much services and support to our clients.
We shared our expertise and knowledge through numerous what the knowledge virtual meeting and published articles all of which were well received and much appreciated.
How did these ongoing contributions to thought leadership during this crisis.
Turning to the quarter results.
We reported adjusted operating EPS of $1.36 for the quarter and I'm pleased with these results in the context of goods pandemic environment.
Specifically supported cold at night Gene claims in the quarter totaled 161 million of which 128, knowing when the U.S.
Adjusting for cause of death reporting like an idea.
Pulled it might seem related claims cost in the quarter are estimated to be 300 million globally of which 240, knowing where in the U.S. individual mortality business.
Well, maybe 60 million claim costs were mainly in the UK in Canada.
Hold at night chain claims outside of the U.S. individual business, one large part offset by favorable morbidity and non coded whiting related mortality experience.
We have like a mortality models functions and scenarios to reflect our own emerging experience updated information and data on the pen dudnik any consideration of the ongoing uncertainty on the future passive the virus.
These updates have resulted in an overall modest decrease in the estimated impact on our results. Despite projecting a higher alternate level of U.S. population does.
Like in some of the conservatism, we previously highlighted when describing my model.
Jonathan corridor.
Global cheese first off the charts will provide additional information on the bottle updates shortly.
Beyond the effects of cold that night King we were pleased with the performance of our business as results for most operations were in line or better than expected and some operations performed particularly well.
We have long highlighted the power of the earnings engine the husband built over the last five decades and highlighted the diversification benefits from our global platform.
This quarter again reinforced the resilience and the value of that platform.
We completed several capital motivated financial reinsurance transactions in the quarter.
This quarter, we deployed a minimal amounts of capital into imports transaction in part, reflecting increasing competition, especially on the like asset intensive opportunities.
We continue to see opportunities in North America, Europe, and Asia, we're chasing a prudent balance and disciplined approach to capital deployment during this crisis.
Carefully weighing opportunities against long term financial and strategic value.
We had been and we'll continue to be very good long term stewards of our investors capital.
Although there remains some challenges unknowns RJ enter it depends on mix in a position that's great.
During the quarter, we took proactive a measured options to raise capital to further strengthen our balance sheet and build additional buffers.
We also reduced risk in our investment portfolio increased liquidity and ended the quarter with excess capital of 1.4 billion.
I think there's quite you about evidence in our results this quarter to demonstrate that our underlying earnings power is largely untapped and that we are well positioned to successfully manage through a period of continuing uncertainty for the virus and the global economy.
We are well placed to emerge from this pandemic in good shape to capitalize on opportunities and to continue to build on our strong track record of creating long term value.
I remain confident in the long term value for our business and the RJ team and the strength of the arching franchise.
We are leaders and my wife and helps reinsurance industry and expect to remain shelf for many years to come.
Thank you for your interest in Archie I and I Hope you all remain safe and well.
Let me I'll turn it back over to Todd to go over the detailed financial results.
Thanks Anna.
I will review the financial results like some comments on investments RJ capital and liquidity position.
Beginning with consolidated premiums, we reported bringing growth of 1% for the quarter.
Do you had a global or constant currency basis with approximately 2%.
Also in the mid to high single digits prior periods locked in the park, a temporary slowdown of groping age or markets.
Locked down actions as well as expected reduction in Australia.
Turning to the segment results listed on slide six and seven <unk> earnings presentation.
Starting with the U.S. segment.
The U.S. of Latin American traditional business was negatively affected by excess individual mortality claims costs of approximately $240 million.
We believe it's got the extra mortality was related to cope with my team.
So our analysis of the board you bet specifically.
Let's give about of the claims this quarter have been reported with cold to bite gene as the cause of death.
We assume with similar percentage of cost remaining claims what we did not happen no cause of death, yes.
The majority of access claims were concentrated in policies over the age of 70 and policies underwritten more than 15 years ago.
What's your consistent what the worry golf football dividing selection of the potential for more co morbidities.
Yeah.
Since all the highest mortality blade shows in states that recorded the highest general population cold the 19 does.
Typically New York in New Jersey.
Tell the ratios in most states will significantly elevated compared to other states.
Our conclusion, but also consistent with C.D.C. report.
A significant levels of excess deaths in the quarter that indicates that the vast majority of these are believed to be cold like two years later.
Also our U.S. conditional segments, both or U.S. group individual health lines of the business reported results that were modestly better than our expectations.
Oh, the U.S. and Latin America asset intensive business reported the good results benefiting from the rebound in the equity markets.
You have some Latin American capital solutions reported an increase in adjusted operating income, resulting from new business School.
Moving to Canada.
Digital segment had another good quarter. This group lucky to moderate amount to cope with my team claims partially offset by favorable performance higher group business.
Absent the impact to cope with my team candidates additional segment had another solid quarter.
The Europe Middle East Africa segment, or traditional business performed inline with our expectations overall.
The segment was impacted by moderate amount was cold underwriting claims in the UK.
It was offset by favorable morbidity.
All right across the region and favorable mortality in Continental Europe.
The biggest financial solutions business had a very good quarter slumping favorable longevity.
Quoting some point catch up reporting.
Due to the lags and recording.
We boats before any material impacts from Cobra by Jean.
We expect to start seeing some benefit in the second half of the year.
Turning to our Asia Pacific traditional business age there had to salt water benefiting from inline underwriting experience most geographies in line and no real outliers.
Also in Australia with better than expected that breakeven as a group business was profitable, but individual disability was at a loss.
Or Asia Pacific Financial solutions had another very good quarter.
Benefiting from the growing enforced and do business activity.
Corporate and other segment reported pretax adjusted operating loss of $11 billion.
Lower than the average run rate, primarily from lower incentive compensation and travel related expenses.
The effective tax rate on pretax adjusted operating income was 20.3% for the quarter.
Below the expected range of 23% to 24%.
Primarily due to the geographic mix of earnings lower global intangible low tax income or guilty and favorable adjustments some bottle tax returns.
Looking at slide eight nine and 10 in his presentation.
As we expected dissolved the reversal of certain first quarter below the line items based upon a rebound in the financial markets and are influenced by hedging and embedded derivatives.
The bond spreads portfolio investment yield you ended the quarter at 4.07%.
Relatively unchanged versus March 31st.
<unk> increased cash levels, but some downward pressure on yields.
The lower new money rates.
Variable investment income improved slightly versus the first quarter, but was still below the average run rate that we would expect.
We believe our investment portfolio with defensively position coming into the crisis.
Overall, the portfolio credit impairments were relatively modest in the quarter.
Oh portfolio average quality of the rating was maintained.
Also took actions to reposition public securities will be assessed the risk reward outlook had become less favorable.
On slide 11, or excess capital position of increased a 1.4 billion.
Following the capital raise the 500 million the problem solved.
And that 200 billion senior debt issuance.
I'd like to point out that our earnings engine was strong enough to absorb the impact of cobot like gene this quarter.
And our organic growth and from our dividend.
[music].
You had considerable liquidity up into the first quarter.
Added to that in the second quarter, its cash and cash equivalents increase of 4.3 billion from 2.8 billion up you into the first quarter.
RG <unk> leverage ratios or at a comfortable level relative to our targets than others.
Current liquidity and capital levels.
On what the underlying earnings power of our business reinforces our confidence that we are in a position to manage the uncertainty of the garden bar and to capitalize on opportunities support our clients and continued strong.
Strong track record of creating long term value.
Looking forward, we expect to see some level of ongoing cope with Nike impacts that will negatively affect our earnings. Although at this time is difficult to accurately predict the timing and the ultimate impact.
We expect that RG <unk> strong franchise will continue to produce long term value.
Our shareholders, however, given the obvious hurdles and uncertainties it'll be difficult to achieve our intermediate targets in the near term.
Well provide more information as we gain greater insights into the ultimate impact depending on that.
Well now turn the call over to jump in quarter, four global Chief risk Officer, who will provide some thoughts on how we view covert by cubic so looking forward.
Thanks, Todd just wondering will provide an update on our assessment of the potential future impact could be 19 corner global mortality businesses.
I didn't mention.
Finally, the mortality claim cost for each general population doesn't crude but this is expected to be partially offset by a higher plausible range of general population does in particular in the U.S., Let me walk through there's gonna give more detail.
Oh last quarter, we provided an illustration of the potential impact could be 19.
Probably claims based on a scenario, which included 100000 actually looks at that time, our estimate of extra pretax mortality claim costs for this scenario is between 400 marine and $500 million.
We have updated remodel.
Remember general population desks, we're now estimating a range of 200 300 million pretax of additional mortality claim costs a decrease of approximately 200 million.
These figures are shown on slide 13 in the presentation true.
Several key assumptions that are used to estimate the impact of general population Capstone are insured book of business with updated based on our own emerging claims experience as well as we're getting better.
Sources.
Actually model change that drug this reduction in estimates for the larger assume selection factor between insured lives and during the population lives.
In other words, we expected to covert 19 related mortality in individual school life insurance.
We had previously.
We also made another assignments, including foreign country specific age and gender mortality rates to our insured book.
These impacts were less material somersaulting increases to future claims with some resulting in reductions.
Overall, we believe that these updates better calibrate our models to be experience, we're seeing other general population in the markets in which we operate.
And you can appreciate I models based on a number of underlying assumptions, which are set based on analysis of external data already claims experience as well would be application expert judgment and therefore estimates are subject to a range of uncertain.
That's provided last quarter for sure we get on slide 13 of the material. The mortality exposure is globally diversified with more than half board magic risk. It started the U.S. However, given the current with of course of the virus like demographics that our country exposures. We expect the U.S.. We continued to be the key driver of cooking 19 mortality claims for RJ.
In the near term.
The next largest mortality claim costs are expected to be in UK and Canada, although both are expected to be considerably lower than the U.S.
Slide 13 also shows estimates your models for every 10000 population das for these three countries in order to calibrate our claims estimates to future additional cobot 19 general population Ducks.
Slide 14 takes these estimates for the U.S. Yoo carried in Canada as old estimates the older countries, where we have mortality exposure and apply them to scenario.
No general population parents, starting in Q3, 2020, and beyond 200000, U.S. 50000, Okay and that was any Canada and representative amounts in other geographies.
Scenario you'd have to make future additional pre tax mortality claim cost between 400 million and $600 million.
Obviously, they're running to level uncertainty regarding a teacher passes the virus and ultimately impacts the population there.
Finally, it is worth knowing that our modeling continues to assume that go to 19 claims are marching up extra claims not accelerations of claims that otherwise would occur over the short or medium term.
You pack is unknown and difficult to estimate at this time.
It's a range of mortality claims provided does not include any future benefit from our longevity business. Although we would expect if you're part of the impact to earnings as experienced emerges.
I'll hand, it back to Todd.
Thanks, Jonathan.
That concludes our prepared remarks now like to open it up for questions.
Thank you.
Ladies and gentlemen, if you'd like to ask a question over the phone today. Please press star and then one at this time, if you are using a speaker phone it might be necessary for you to pick up your handset or depressed functions on a single can reach our equipment.
And the interests of time, we will try to limit the questions to one question and one follow up question.
And we'll take our first question from Humphrey Lee from dialing in partners.
The mole physical picking their questions talk something you'll come prepared remarks, you talked about you didn't really see watch a bolt on longevity. All says Oh from Goldman mentioned this quarter, but expect that to even worse in the second half, but if you don't think last quarter, you guys talked about 10% caused a potential.
Set astutely.
How do you think about you could potentially benefit it's just too I mean look it seemed like it can be died of dental work.
Okay.
Well good luck for your question three but yeah, we didn't see a lot in the first half of your because it's all reporting lag on that business because that will form the underlying scheme to the insurance comes and ultimately to us.
But as far as the potential offsets.
We still view that sort of 10% range as far as an offset to the mortality is still these mobile now estimate of helped to laws look at it.
Okay got it all.
And then you go to be Mark you talked about the he can't be Pike why are you that's why I, sometimes it become more to it.
[noise] competitive for them to see opportunities in nature.
Other countries interest me he loved it was important things just kind of yeah I'll look forward looking for capital deployment in the second time, what did you.
Sure.
Thanks, Good morning, Humphrey I didn't say and reemphasize overall, we see a generally healthy pipeline I'm I'm going to ask a one should provide a little bit more color on the pipeline and the competitive environments blend.
Sure. Thanks, Anna you don't think Humphrey in normal times the deal processes are fairly lumpy.
And I think that applies here as well.
Generally speaking we are as Todd mentioned seeing a very healthy pipeline.
Although you know we've got different levels of competition at different times.
I think generally speaking.
Asian businesses you.
Alluded to I think is.
Pretty strong and while in the U.S., there's a certain lower competition I I didnt diminish.
But we do have opportunities and we're looking at them. Similarly anything to be I think there's a a reasonably healthy pipeline as well, but I wonder I want to reiterate Oh you know these times I think we're going to see some lumpiness in terms of closing those transactions.
Yeah, and let me let me provide.
Some additional comments are finding a humphrey.
We've shown in the past that we navigate periods in pockets of change in competition, we did that by focusing on off on opportunities that play to our sweet spot light CCAR capital efficient solutions was very good at both solutions and we had a very good corridor and.
And and executing on those transactions and then as I look at this low interest rate environment. It's we're facing that's for a protracted period of time I would expect to see greater demand for those solutions and for general product innovation as well.
Lets continuing demand for it doesn't innovation and the underwriting process.
All of that really plays to our strengths, our strengths and product development and underwriting.
So I would I would echo <unk> comments, there somewhat lumpy, but we got remaining very focused and we are playing out to sweet spots, where we do have a an advantage.
Do you think putting a woman who make the the them the lumpy though.
More lumpy, so I'll, just give them to be kind of them and when they.
Present, it to eat you have wouldn't you can give you a premium pool all wilkinson.
For the next couple of years.
I'm, sorry, I Didnt catch the the last part of that question. It was a about.
Yes, the lumpiness, increasing do we expect all bumpiness, but that the premise of your question.
We also like so do you think you determine Birmingham, <unk>, Lumpiness Roche and show that affect.
The trade in fact, you you're kind of premium growth a little.
The Lumpiness, where we're buffer of we're referring to our enforced transaction our premium growth is in large part driven by our underlying organic slow business because even course transactions are in large part feebates first spread Dave.
Transactions, although we do do mortality blocks as well.
In terms of de organic premium growth I can't get the you know a reflection of the temporary environment, a walk downs and most parts of the world a would expect fast as we come out of the crisis to pick back up or potentially even stronger.
With some pent up demand.
But that address the question you are asking.
Yes, I think it fulfil that.
Okay.
[noise] and we'll take our next question from Andrew.
With that finished.
What.
Oh, sorry.
Thank God.
I noticed.
Slides 13 that there's no.
Mortality claims cost sensitive.
And I'm wondering gifts.
I should take that.
Such that you don't want to do you have to pay them very low mortality.
And then part of the question it looked like Australia was breakeven in Todd said on the call that so.
Number was better than expected so.
Should we think this group club business profitability.
Docs moved or.
So to see losses again or is this a good runway.
Good morning, after I'll turn the first question over to Jonathan No mortality question, and then apps Hod and Glenn to address to Australia, because it questions. Jonathan can we start with the mortality question.
Yeah, Yeah. So we have provided as you noted the calibrated impacts to the U.S. you can't Canada on Slide 13 at this point recommending that the Threed those countries combined will account for about 90%.
The 19 mortality.
Claims costs, that's why we didn't break at all and get a country. So I think your assumption that are current projections assume that's being back relatively modest or small teenagers Kirk.
And next or interest.
That's true.
Exposure amounts as well.
Graphic distribution of our business and be.
The athletes and.
Hello.
Sure.
[noise] then on on that.
Oh, sorry go ahead.
Yeah, Hi, Andrew This is Todd jobs earlier, you know, we're very pleased to see the results that we've seen through the first.
Six months' given your what we're seeing.
Yes.
Year to but I think it's too much.
Too premature to suggest that Weve you know.
Corner, you know, we're continuing to manage the in force no very closely managing planes, you know very closely and it's good to see the group of warming.
Better, but the individual disability is still no sporting some walks and so we still need to continue to keep an eye on the entire no block of business will continue to smoke warm rate increases increases it exactly can so when somebody it's good to see the result, so far but I'm I'm hesitant to say, but.
We've turned the corner, we still need to keep a buyer on it going forward and we still could likely to come volatility.
I see I mean, just a quick follow up and swipes working you sites or an additional 200000 U.S. <unk> general population, that's starting to too.
And I'm wondering if that's just kind of like we had been scenario where is that what you think it is likely to occur and if so what do you.
What are your underlying assumptions.
Yeah, Let me, let me take that one so you know again because of the uncertainty that you know.
Exists around you know all aspects of cover 90, we don't think it just one scenario.
Okay got it across a range of outcomes, but when considering the.
400, 600 million scenario that was listed here I.
Your assumption it could range that we think as far as a more reasonable but.
No no one including ourselves can really predict opening is who's gonna and upset was meant to provide a demonstration of a plausible outcome from my perspective.
Which which kinda leads me to wonder like 200, he's a very big number moving forward any any assumptions that you know you're assuming like a big second wave. The so called at 19 is that right.
Yeah, I mean that things are getting you look at multiple sort of views on no kind of second wage labor and various condition and really from our perspective, but the timing of back towards the incidences, where they're just take away before not probably doesn't make much difference. It really is ultimately the numbers yet.
That occur that drives our corporate results sooner we consider.
Options, but.
Given you know to kind of where right now and the potential for look it up into the future, making sure that this is a scenario looks like a plausible.
Yeah, I guess, what Todd maybe <unk>.
Yeah, there's probably with the add on to that real quick you don't need it.
It's very difficult I'll begin they want to predict the ultimate outcome what differences.
Everything that's going on in uncertain and that's why we did provide so you can sort of pick your own you won't be hopeful but definitely provided because that's that's and looked at this point. What every 10000, the general population destinations as far as we control no claims that too.
Got it. Thank you hopefully that's conservatives like your original sensitivities.
Well move onto our next question from Jimmy Bhullar from JP Morgan.
Hi, good morning.
My first question is just on how you define access capital. It's all going companies talk about excess capital to these equity at the same time. So maybe you mentioned an excess capital number.
In the past as well, but they haven't given a lot of clarity on how you compute the numbers so.
That's the first thing and then related Lee.
How do you think about deploying the capital if lets see little bit ends up being a manageable risk from a mortality standpoint, and credit as sort of in mind, but your expectations clearly done they've got more coupled with the these than you would have done would have been absorbed but these things. So how do you think about deploying but when do you.
Start to.
Become more proactive and starting to deployed.
I just wouldn't stop all I've talked to address your first question on hobbies decline excess capital and yeah I'll come back in and provide some thoughts on your second question around <unk> capital management, and an awful lot Todd if he has any additional comments to cook.
So Todd Newstar, but the definition.
That's what we do first and foremost would need to make sure all the various Oh, you know operating companies around the world has adequate capital to meet or the local.
Regulatory needs.
Also we look at our own.
Economic capital model.
Internally to look at various levels of capital at all so that helps form our view of.
Some of our underlying risk limits and then.
We also paid a lot of attention to the rating agencies no bottles, because ratings or no very important to us because we want to be viewed as a very solid long term counterparty to or no clients went a long term business, what's important for them to view us as a very most wrong counterparties. So looking at all those things and maybe tilted.
The little bit towards the rating agency models, we want to make sure will always problem appropriately capitalized to maintain our ratings and keep our operating companies.
Whether he'd be from a local perspective.
Okay.
And then on your second question I'd start by saying that site. During this crisis in this crisis, a we continue to work on opportunities, where we've been active I fully expect us to continued to be active, but we're balancing that with being prudent.
Too so that we do remain well positioned to weather trick now in terms of you know when he doesn't that balance potentially start to shift I would say, we would me no certainty and clarity around the virus around the economic impacts and then some stability.
Outlook as well and.
You know as we look out we don't expect that to happen in the short term. So so we'll continue along the way we have been so that's quite just started well we're continuing to support our clients actively engaged I haven't seen any any change and that activity 10 states.
Apps pick off the bat I am doing well be very.
Prudent and looks more good long term opportunities on balance that against the continuation of the environment.
Todd is there anything else that you've looked like to <unk>.
No, but I think you covered it in effect.
Maybe I'll just ask one more on the mortality that you've seen in your primarily in the U.S. business this quarter.
You look deeper into the average age and other factors of the claims to sort of discern if.
Clearly all the claims or pull forward right at some point every claim comes through in the life business, but if you try to determine how many of them or maybe a pull forward by like a year or two years versus 10, 15 years and obviously the older population the better the more recent to pull forward.
So but any comments on.
How that affects your view of earnings over the next couple of years positively or negatively.
Yeah.
Oh, all Oh.
Apps gets Jonathan Todd or would like Chad.
The question about you know do we think any of the claims are accelerations of the future period claims very hard to answer that question very hard to estimate that at this point, we think it's certainly possible that we had some acceleration of the claims given less bad that.
A very large part the majority of our extra gets more concentrated at age 70, plus one in particular 80 Pos.
HM.
And at the end of the day bodies like people can only die warrants.
But at this point, it's very difficult to put a figure on yet as to how much of that he would have expected to see you know but of course of the next few periods.
Jonathan or Todd.
Yeah, No I think that's exactly right and that's you know again, just another reason why for extra mortality projection going to go for their basis, we haven't assumed acceleration, it's consistent clicks and.
But the only thing I would add is you know I view, what we're going through now is a temporary period of elevated.
Claim activity and well be get through what we might be able to see that some of it was a real acceleration but.
All that being said I think the overall earnings power of the organization like probably including we love traditional mortality business will be in past when we get to the other Todd.
I would actually that extends the games or pull forward from one or two years.
That doesn't value future earnings is lower but the earnings next year would actually be higher not lower right. Obviously, we don't does that assumption in plot.
Does that assume that the claims are intact going forward, one or two years, but and but if that is true then all else being equal your earnings should be better next year than they would have been otherwise.
Right.
Let me start as it's hard.
Hard to gauge no doubt research with everything once they don't occur.
Thank you [noise].
I will take our next question from Ryan Krueger from KBW.
Hi, Good morning, I had a question on longevity.
In the UK you reiterated the rough assumption of about 10% upset some longevity to your overall.
I'll be with.
There.
Each of your lunch I was interested in the play anywhere, but that's been pretty significant but can you.
Spec.
Hi.
In the near term outcome or elevated longevity offset.
Yes.
Fine I I'd say difficult to a categorically say, yes, but we think kits are likely to be the case, given what we've seen in the UK, but as Todd mentioned earlier with the lags.
We haven't we.
I haven't seen any of that to date and it'll be more all you know a a situation going forward.
Got it.
And I guess that you could you give us a deep.
Maybe just focused on the U.S., yes, but [laughter].
Typically expects for insured versus population.
Mortality and then.
How do you think it's coming through for <unk>.
He was kind of normal difference between though.
Yeah hurt because that question I'm going to turn it over to Jonathan.
Yeah. So in our go forward projections.
What we're assuming now you know across most markets are in it that the difference between ensure general population coverage because if it gets would be basically the same or equivalent to what we're seeing just for all cause mortality.
Actually assumption that we were we weren't sure I wouldn't be spivey determiner model last quarter, just as like a data like Saudi but now we're more comfortable you know applying that that's actually a differential that would otherwise cease all cause mortality again based on her experience as well as though information that we're looking at externally.
Thank you.
And we'll take our next question.
Yes from autonomous research.
Hi, Thank you I'm just a follow up on the longevity experience in EMEA and I think this is something you've seen as a favorable trends for a bit now that's hoping you could maybe quantify the amount of the benefit or catch up this quarter and then talk about what is a typical lag so that the experience you're seeing now.
Kind of.
When is that.
Sure when does it actually incurred and.
How long does it take to come through your results.
Yeah, I mean, let me ask Todd to respond to your question.
Okay, Yeah, no yeah, you're right Eric overtime that there's been some lumpiness them, though.
No the UK I remember the UK longevity business, given never get catch up in reporting.
That type of things I think you need to look out is little bit more over a longer.
Here either.
We still think you know the run rate that we'd been mentioning for the past.
A couple of quarters at least for total Amir MEP 60 to 65 million range is still sort of at the appropriate run rate to causing them on so that really hasn't.
No change at this point, if we do see from time to time other quite catch ups. Unfortunately, there are usually to the positive because it's usually getting updated.
Information and Truing up the inventory and those parts of thing so it's.
I don't have that quantification of the.
Pacific true up for the quarter, but again I'd probably back to the looking out that told all of your run rate of about 60 to 60 partner.
Got it no. That's helpful. I mean, I guess in general the trend has been pretty consistently favorable I think relative to your pricing assumptions. So what do you see is driving that.
And I mean does it seem like something that May continue.
Well I would offer up heart, so part of the answer maybe that the temporary slowdown in mortality improvement.
And have their impacting obviously in the other direction the underlying longevity business there it could yeah. It could be part of that part of the region, it's very difficult Eric to just really provide very detailed.
Attribution, it's just that you know when we when we price long term business, we have to SAP, so long term assumptions and.
They don't necessarily come in lock step you know smooth, there's some lumpiness there sorry, there's some volatility both short term intermediate term, but we're very comfortable where the performance of that business and a as Todd mentioned and as you alluded to it's been performing favorably.
For Oh, good not period of time.
Thanks, and then if if it could just switch to Asia I'm, just curious about the near term organic growth outlook and also if you could talk about any potential impacts from some of the uncertainty in market disruptions at Hong Kong.
Oh.
Thank you let me ask a land to address your question that's funny Alan.
Yep. Thanks, Anna you know I think as you pointed out are there has been quite a bit of disruption, particularly in Hong Kong over the last year.
Even pre covert so the only thing.
We can expect that the the near term might continue to be a little bit below our normal run rate.
We fully expect over the course of say the next year or more that or new business would bump back up to what I expected levels.
Got it thank you.
We'll take our next question from Tom Gallagher from Evercore.
Good morning, So first question.
Do you think the a pandemic will impact session wage or.
At all so the primary life insurance you are you seeing any any change there and also do you expect any impact on the terms and conditions on both new treat each and enforce tree trimming your renewals.
In the wake of what's happened here or Jack Jack continued to be pretty stable.
I would I would respond by saying, it's too early to really gauge what will happen to session rights I could certainly offer up that they need value of reinsurance has again highlighted during this pandemic and and and so expect.
Batch both style broken the underlying insurance market itself, you know consumer seeing the value of insurance.
As well as our clients the life insurance companies seem the value of not just risk transfer but also other.
Reinsurance solutions show. So yes, I think we we could see that I would expect to see that but it's too early to say that we certainly on the session side that machine it on the session side.
Perhaps an awful lot stuff and then any further thoughts that you would like to add.
No I I think you're right down as you mentioned, there's there has really been no impact on cession rate so far and at this point no reason to believe that there'd be any downward pressure on that on terms of terms and conditions.
Again, probably too early to tell but at the end of the day.
I think we are a reinsuring, a life and whether that lifetimes or through the course of the flu or or pandemic I didn't see us and certainly insurance companies on the front end, excluding that so I wouldn't expect or any significant changes in terms and conditions.
Okay, and then my follow up I guess is.
Kind of a follow up to a junior asked before about the way you're thinking about capital adequacy risk in force does it does this caused you to reconsider.
How you're viewing just overall enterprise risk relative to the capital your holds.
Given the equity raise here.
I guess just a related question would you consider.
The two really growing some offsetting register mortality, whether that's adding more longevity on morbidity rushed to the book, that's a way to better balance it out to you know cold, calling lessen the pandemic that exposure that you would have we're or how you're thinking about that overall and Todd how do we did we bought.
The strategy, just yet and that you ended up raising equity.
Alright, let me, let me take up parts of those questions. So let me address the raise equity a question and then on Alaska, Jonathan to speak to your capital questions. So is it specifically to.
Too.
Finally raised equity.
I'll start by saying when we look out at the crisis.
We could see a quick and we felt that the pandemic would likely continue until there was therapies are treatments are vaccines.
And the timing of those vaccines and therapies and tight in certain and in addition to the virus the picture with developing on the impacts to the global economy on just how much damage was being done and on the uncertainty around.
Alan when and where how long a period of time, even see every coverage show, stating that we felt it was prudent to increase our capital buffers, because we're in a long term business and strengthened stability our important for protecting the valuable franchise. We've spoken about this morning, and making sure that worldwide.
Opposition to pursue these attractive opportunities gross long term value opportunities.
No if I look out today as we look out today not a lot has resolved and and we continue to believe that increasing our buffers when's the right decision.
It was a pretty choice and it's consistent with how we manage shareholder capital over the long term.
Look we're not at the end to us and I doubt it by saying I think it's premature to draw any conclusions.
At this point.
And maybe that that all.
Jonathan to address the rest of your question.
Yes, Thanks, just to come out from a capital perspective, it on still quite comfortable with the the level of acquired capital that we have set up.
From an internal economic basis.
[noise] accounted for in attendance exposure. So similar concerns there and then diversification in it I think you asking about diversification strategy I guess I'd say that you know over the last several decades I think we had been employing occurs that's gotta juniors vacation and Ah you know looking at things like Ingevity morbidity and.
I'm trying to piece as you point. So I think that you know has I served as well in this environment and you know I guess.
Stranger, having now I'm sure.
Factor into our thinking on a go forward basis too.
Yeah.
And maybe I can add one out there maybe I can just one other thought which is you know from time to time, we have looked at buying or some type of pandemic protection be bad a cat bond or some other instrument.
We always found that was to get a meaningful amounts of protection given just the scale of our mortality business. It was hard to find capacity and then the cost for too expensive for the protection provided some we didn't and continue not to see good benefit cops options.
Show the way, we look at Atlanta, Jonathan highlighted is it it's by using diversification by managing risk appetites, that's a risk framework through which we look at our business and that will continue to do so going forward.
Okay. Thanks.
Our next question comes from Dan Bergman from Citi.
Thanks, Good morning to.
To start again, excluding the capital raises it looks like excess capital was roughly flat quarter over quarter, a third looking forward at buybacks and block reinsurance deals remain minimal on them.
Brand around the current level, the second quarter earnings at a decent proxy for the level of earnings you'll need to generate to keep excess capital flat going forward or are there other adjustments are factors maybe thinking about.
Yes, Todd can I ask you to address the question. Please.
Yeah, Dan I'll call. It that's what it's probably not a bad way to look at it I think if we look out that what are you don't earnings power.
It can be X cold, but for the remainder of the year. Then we went through what are.
It is overtime for coal, but as you can estimate how much of that would be sitting on the second half the year.
I think we'd have the earnings but.
Farm or organic growth as well as well from the dividend and they've been they'll just sort of the unknown would be how much capital we potentially deploy into any imports transactions that are look attractive.
Got it that's a that's really helpful. And then maybe just a quick one on corporate there should we expect the loss that remain favorable prior guidance near term.
Level and maybe some other expenses are many depressed or prior kind of quarterly loss gotten still a reasonable expectation.
Yeah. So for now I would say the 25 billion loss on average for quarter still reasonable we did have a little bit additional reduction in Los Angeles, and the second quarter here, but I think we'll be maybe hopefully comment a little bit under that the Gulf War, but I I wouldn't provide.
It was an updated average loss at this point, but some some of the items like travel should maintain the lower level through the obviously to the rest of the here.
Got it thanks much for taking the questions.
Our next question comes from cost us.
Yes, so legal in general.
I guess like like I said, it goes look up and so.
Regarding the access company does and ratings I think you mentioned the public safety the gold igniting doses.
By the gotten in Colombia.
What the baby, but even something buffeted on some of the medium from what that was made in Colombia to see the Bulls, who have maintained the rating.
First as I said, because you listed.
Therefore, I'm doing box it got to be Bloom and.
And I'm kind of asking whether do you expect couple of months walk you through you pulled slaves experience.
Political she the big buildings left the night before things.
I think that.
Like reporting a comment wins in respect of our longevity business, which we expect a should be a net positive to earnings that we have on our mortality business.
We have.
It all of the incurred claims in the quarter and and do not have any lag that would then be.
The felt in the following quarter I'm understanding the question odd.
Andy.
And my thinking about that question correctly.
Perfect. That's that's right based on your your answer I agree for your comments I agree with I did not completely so good.
Here all the questions is breaking out for me.
Yeah, Yeah cost, it's just that it does that address your question.
Yes, yes, it does because most of the Bugs you said a couple of Bloom and I I'm going to people would be like hey, let them defaulting, but yes. It does have its funky.
Thank you.
And we'll take our next question from brand awareness I mean.
Hi, guys. This is Mike word on for Brian I, just kind of expanding on that that natural hedge phenomenon that we've spoken about in the past. So you mentioned you know when you when we've got elevated mortality like this of course it comes through in the period that did it occurs maybe there is little lag but.
Kind of wondering how how long does it usually take for that benefit to flow through in the longevity Pete.
You know does it take quarters or years, just kind of curious how we should frame, but thinking about that benefit that offset.
Yeah, it's closer to the first switches quarters. It it's not like five years, obviously, and we have a number of transactions and that means a number of clients and and clients have different operations and then the underlying.
Skiing pension schemes themselves also have you know.
Underlying operational comply and operational processes. So on average in general I think where did you know we're looking at it from a few quarters perspective, not years perspective necessarily Todd correct me or whatnot chime gardening.
Yes, I agree with your comment.
Yes.
Okay and so that's helpful. So I'm just thinking about you know so you said you didn't have any of that longevity benefit this quarter, but.
If we back out to a 300 million affects us cold claims I think you know that would translate into a new plants for the growth over $5 per share, maybe maybe I'm wrong on that but I'm. Just curious if you could help us understand or quantify the other favorability that that contributed this quarter.
Yeah, I feel like there were things going and other direction. So I've been asked Todd just give me just some high level overview somewhat the other items Ted to help stops train that Sam.
That calculation just did.
Good either in addition, there is looking at the.
For the elevated mortality.
Impacts that you could add back you also need to look out there were some expense savings.
Quarter or that would need to be added back from adjusted related to feel travel as well as a significant component of the expense savings related to compensation and within the compensation related to.
It was sort of variable compensation that longer term incentive composition compensation part.
Adjustments that we made given the underlying experience that we're going through this year, it's going to impact some of those longer term no program. So we need to do adjust with after you need the.
Maybe reduce the mortality savings ourselves for additional expenses.
And I'd put the baby's expenses is there a rough number but maybe it's around 50 cents a sure.
And I would add one other Todd and that is a 300 is the global estimated cost to 40 in the end to you last individual the other 60 outside of that operation I recall that.
It was offset in large part due to favorable performance a in the more morbidity business and other non mortality I think that you know jumping back up for that 16 somewhat aggressive.
Because it would suggest you know a permanent that contribution from yeah, you know and continuing contribution from that of the performance and although we do I forgot to be the case and that's that's that could be somewhat aggressive.
Thanks very much.
And unfortunately, ladies and gentlemen that has all the time, we have for questions thing I would like to turn the call back over to Mr., Todd Larson for any concluding remarks.
Okay. Thank you well everyone. Thank you for joining us on our second quarter earnings call today.
As always we appreciate your continued support and look forward to the 'cause 'cause your dialogue as we go forward. Thank you very much.
And once again, ladies and gentlemen that concludes today's conference I appreciate your participation today.
[noise].
[noise] Oh.
Oh yeah.
Oh.
[noise].